As shown in Table 1, there was no significant or clinically relevant difference between groups in baseline characteristics including age, gender ratio, body mass index (BMI), time since diabetes diagnosis, time since the initiation of insulin pump treatment, and insulin daily doses. This evidence concerns the gene INS and diabetes mellitus.